Category Medical Devices

Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints

Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced…

Read MorePositive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints

ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies

ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies ENDRA Life Sciences Inc. (NASDAQ: NDRA), a leader in Thermo-Acoustic Enhanced UltraSound (TAEUS®) technology,…

Read MoreENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies